We are pleased to announce that the LUGPA alternative payment model (APM) has been officially submitted to Physician-Focused Payment Model Technical Advisory Committee (PTAC) for review. This proposed APM is the first urology-specific APM submitted to PTAC/CMS. This APM addresses newly diagnosed patients with organ-confined prostate cancer and optimizing patient-physician decision making regarding active surveillance and active treatment choices. The APM should soon be posted to the PTAC website for public comment. LUGPA has released a statement regarding its APM submission which can be read here.